Investigational drugs in systemic vasculitis-Reference-Cited by-同舟云学术

Investigational drugs in systemic vasculitis

Published:2017-08-04 Issue:9 Volume:26 Page:1049-1061
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Mirouse Adrien¹²³⁴,Cacoub Patrice¹²³⁴,Desbois Anne Claire¹²³⁴,Comarmond Cloé¹²³⁴,Pagnoux Christian⁵,Saadoun David¹²³⁴

Affiliation:

1. Département Hospitalo-Universitaire Inflammation-Immunopathologie-Biothérapie (DHU i2B), Sorbonne Universités, UPMC Université Paris 06, UMR 7211, Paris, France

2. INSERM, UMR_S 959, Paris, France

3. CNRS, FRE3632, Paris, France

4. AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Médecine Interne et Immunologie Clinique, National Center for Autoimmune and Systemic Diseases and for Autoinflammatory Diseases, Paris, France

5. Vasculitis Clinic, Mount Sinai Hospital, University of Toronto, Toronto, Canada

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2017.1361928

Reference151 articles.

1. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

2. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis

3. Alternative Complement Pathway in the Pathogenesis of Disease Mediated by Anti-Neutrophil Cytoplasmic Autoantibodies

4. Neutrophil extracellular traps can activate alternative complement pathways

5. Complement Activation Is Involved in Renal Damage in Human Antineutrophil Cytoplasmic Autoantibody Associated Pauci-Immune Vasculitis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biologic therapy in large and small vessels vasculitis, and Behçet’s disease: Evidence- and practice-based guidance;Autoimmunity Reviews;2023-08

2. Unraveling the Immunopathogenesis and Genetic Variants in Vasculitis Toward Development of Personalized Medicine;Frontiers in Cardiovascular Medicine;2021-09-21

3. Induction Therapy in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Renal Involvement: The Nephrologist’s Point of View;EMJ Nephrology;2018-07-12

4. Antineutrophil cytoplasmic antibody associated vasculitides with renal involvement: Open challenges in the remission induction therapy;World Journal of Nephrology;2018-05-06

5. Conventional and biological immunosuppressants in vasculitis;Best Practice & Research Clinical Rheumatology;2018-02